Summary
Updated Aug 31, 2026
Samarth Kulkarni files SEC Form 4 reports at Black Diamond Therapeutics, Inc. (BDTX). 19 SEC Form 4 filings on record going back to 2024, most recently on 29 June 2026. Most recent open-market trade: sold $469K of CRSP on 24 March 2026. Lifetime open-market sales: $14.21M.
Recent Transactions
20Every recent SEC Form 4 transaction Samarth Kulkarni has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Samarth Kulkarni go back to 2024: 19 primary Form 4 filings, an average of 6.3 per year. 6 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Samarth Kulkarni files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 12 months
- Karen M. Anderson - $9.65M of CNTA open-market activity in the last 12 months
- Carl Dambkowski - $8.65M of ORKA open-market activity in the last 12 months
- Paul T. Quinlan - $5.72M of ORKA open-market activity in the last 12 months
- Tia L. Bush - $4.05M of CNTA open-market activity in the last 12 months
- Joana Goncalves - $3.81M of ORKA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Samarth Kulkarni?
Samarth Kulkarni is a corporate insider of Black Diamond Therapeutics, Inc. (BDTX). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Samarth Kulkarni submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Samarth Kulkarni been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($14.21M) across all tracked filings.
Where can I see all of Samarth Kulkarni's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Samarth Kulkarni and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial